Desmopressin shortage status
No active shortage currently reported by the regulators Mederti tracks.
Last updated 16 Sept 2026 · sourced from official medicines regulators
- Generic name (INN)
- Desmopressin
- Brand names
- Minirin, Desmopresina Teva, Desmopresina Sandoz, MINIRIN desmopressin acetate, Desmopressin Nasal Spray, USP
- ATC code
- H01BA02
- Class
- Canonical INN head (inn_resolution)
Recent shortage history
- Norway: resolved 11 Jun 2026 (began 15 May 2026)
- Norway: resolved 12 Aug 2026 (began 10 Jul 2020)
Frequently asked questions
Is Desmopressin currently in shortage?
No active shortage of Desmopressin is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Desmopressin shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Desmopressine · Desmopresina Sandoz · Desmopressin Nasal Spray · Desmopressin Acetate · Desmopresina Teva · Desmopressin Acetate Nasal Spray
Get alerted when Desmopressin status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.